XTX Topco’s Aethlon Medical AEMD Stock Holding History

XTX Topco’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,668	Closed	-$29.2K	–	4100
2026 Q1	$29.2K	Buy	+2,668	New	+$30.3K	﹤0.01%	3463
2025 Q4	–	Sell	-310	Closed	-$11.6K	–	3270
2025 Q3	$11.6K	Buy	+310	New	+$17.9K	﹤0.01%	2426

Other funds holding AEMD

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

XTX Topco's AEMD Position: Q2 2026 in Review

XTX Topco sold out of Aethlon Medical (AEMD) in Q2 2026, closing a stake of 2,668 shares — an estimated $29.2K sold.

XTX Topco first reported a position in AEMD in Q3 2025 and held it in 2 quarters. The position peaked at $29.2K in Q1 2026. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

XTX Topco reported no remaining Aethlon Medical position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 2,668 Aethlon Medical shares in Q2 2026, an estimated $29.2K.
XTX Topco first reported a position in Aethlon Medical in Q3 2025 and held it in 2 quarters.
XTX Topco's Aethlon Medical position peaked at $29.2K in Q1 2026.
15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.